Yıl: 2019 Cilt: 57 Sayı: 1 Sayfa Aralığı: 52 - 56 Metin Dili: İngilizce İndeks Tarihi: 25-11-2020

The Effect of Bisphosphonates on Lumbar Vertebral Disc Height

Öz:
Objective: Our purpose was to investigate the effect of bisphosphonates on the lumbar disc height, based on quantitative magnetic resonance imaging measurements in osteoporotic patients. Materials and Methods: A total of 74 patients with osteopenia or osteoporosis were retrospectively included in the study. Thirty-seven patients received bisphosphonate treatment and 37 did not receive any treatment. Age, body mass index scores, spine and hip T scores of the patients together with the median values of the disc heights in six lumbar intervertebral levels (T12–L1 to L5–S1) were analyzed. Results: The bisphosphonate treated group were significantly older compared to the untreated group. However, there was no statistically significant difference in BMI scores between the groups. The spine-T-scores were significantly lower in the bisphosphonate treated group compared to the untreated group, but the hip T scores were found to be similar. The correlation analysis in the untreated group revealed a very weak positive correlation between the disc heights and the spine T scores except for the discs between L4-5 and L3-4. Conclusion: We found that, bisphosphonate therapy might be associated with the preserving of the lumbar disc height despite of low bone mineral density levels.
Anahtar Kelime:

Bifosfanatların Lomber Vertebra Disk Yüksekliği Üzerine Etkisi

Öz:
Amaç: Amacımız, osteoporotik hastalarda kantitatif manyetik rezonans görüntüleme ölçümlerine dayanarak bifosfonatların lomber disk yüksekliği üzerindeki etkisini araştırmaktır. Gereç ve yöntem: Kliniğimizde Ocak 2017 - Ocak 2018 arasında muayene edilen osteopenik veya osteoporotik toplam 74 hasta çalışmaya alındı. Bu 74 hastanın 37 ‘si son dönemde bifosfasfanat kullanmışken, bunların 37'sinde bifosfanat kullanım öyküsü yoktu. Hastaların yaş, boy, kilo, vücut kitle indeksi (VKİ) skorları, omurga ve kalça T skorları ile birlikte altı lomber intervertebral seviyede (T12 – L1 - L5 – S1) disk yüksekliklerinin medyan değerleri incelendi. Bulgular: Bifosfonat ile tedavi edilen grup tedavi edilmeyen gruba göre daha yaşlı, daha kısa ve daha inceydi (Welch t-testi, p = 0,038, p <0,001, p <0,001). Bununla birlikte, gruplar arasındaki BMI skorları açısından istatistiksel olarak anlamlı bir fark yoktu. Omurga T skorları, bifosfonatla tedavi edilen grupta (Welch t-testi, p = 0,016) tedavi edilmeyen gruba göre anlamlı olarak daha düşüktü, ancak kalça T skorları benzer bulundu. Tedavi edilmeyen gruptaki korelasyon analizi, tüm seviye disk yüksekliklerinde ve L4-5 ve L3-4 düzeyleri dışındaki omurga T skorlarında pozitif bir korelasyon olduğunu ortaya koymuştur. Sonuç: Bifosfonat tedavisinin düşük kemik mineral yoğunluğu düzeylerine rağmen lomber disk yüksekliğini korumayla ilişkili olduğunu bulduk.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Olgu Sunumu Erişim Türü: Erişime Açık
  • 1.Vernon-Roberts B, Pirie C. Degenerative changes in the intervertebral discs of the lumbar spine and their sequelae. Rheumatol Rehabil 1977; 16: 13-21.
  • 2.Twomey LT, Taylor JR. Age changes in lumbar vertebrae and intervertebral discs. Clin Orthop Relat Res 1987; 224: 97-104.
  • 3.Kwok AW, Wang Y-XJ, Griffith JF, Deng M, Leung JC, Ahuja AT, et al. Morphological changes of lumbar vertebral bodies and intervertebral discs associated with decrease in bone mineral density of the spine: a cross-sectional study in elderly subjects. Spine 2012; 37: 1415-21.
  • 4.Yang Z, Griffith JF, Leung PC, Lee R. Effect of osteoporosis on morphology and mobility of the lumbar spine. Spine 2009; 34: 115-21.
  • 5.Lee S, Nam CM, Yoon DH, Kim KN, Yi S, Shin DA, et al. Association between low-back pain and lumbar spine bone density: a population-based cross-sectional study. J Neurosurg Spine 2013; 19: 307-13.
  • 6.Harada A, Okuizumi H, Miyagi N, Genda E. Correlation between bone mineral density and intervertebral disc degeneration. Spine 1998; 23: 857-61.
  • 7.Ravault PP, Meunier P, Sambin P, Cret R, Bianchi GS. An early sign of spinal osteoprosis: enlargement of lumbar disc spaces. Rev Lyon Med 1969; 18: 603-13.
  • 8.Black DM, Cummings SR, Karpf DB, Cauley JA, Thompson DE, Nevitt MC, et al. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet 1996; 348: 1535-41.
  • 9.Luo Y, Zhang L, Wang W-Y, Hu Q-F, Song H-P, Su Y-L, et al. Alendronate retards the progression of lumbar intervertebral disc degeneration in ovariectomized rats. Bone 2013; 55: 439-48.
  • 10.Neogi T, Nevitt MC, Ensrud KE, Bauer D, Felson DT. The effect of alendronate on progression of spinal osteophytes and disc-space narrowing. Ann Rheum Dis 2008; 67: 1427-30.
  • 11.Prevention and management of osteoporosis. World Health Organ Tech Rep Ser 2003; 921: 1-164.
  • 12.Kayalar G, Cevikol A, Yavuzer G, Sanisoglu Y, Cakci A, Arasıl T. The value of calcaneal bone mass measurement using a dual X-ray laser Calscan device in risk screening for osteoporosis. Clinics 2009; 64: 757-62.
  • 13.Koeller W, Muehlhaus S, Meier W, Hartmann F. Biomechanical properties of human intervertebral discs subjected to axial dynamic compression--influence of age and degeneration. J Biomech 1986; 19: 807-16.
  • 14.Oda J, Tanaka H, Tsuzuki N. Intervertebral disc changes with aging of human cervical vertebra. From the neonate to the eighties. Spine 1988; 13: 1205-11.
  • 15.Frobin W, Brinckmann P, Biggemann M. Objective measurement of the height of lumbar intervertebral disks from lateral roentgen views of the spine. Z Orthop Ihre Grenzgeb 1997; 135: 394-402.
  • 16.Wang Y-X, Griffith J, Ma H, Kwok A, Leung J, Yeung D, et al. Relationship between gender, bone mineral density, and disc degeneration in the lumbar spine: a study in elderly subjects using an eight-level MRI-based disc degeneration grading system. Osteoporos Int 2011; 22: 91-6.
  • 17.Van Der Werf M, Lezuo P, Maissen O, Van Donkelaar CC, Ito K. Inhibition of vertebral endplate perfusion results in decreased intervertebral disc intranuclear diffusive transport. J Anat 2007; 211: 769-74.
  • 18.Cecchetti S, Pereira B, Roche A, Deschaumes C, Abdi D, Coudeyre E, et al. Efficacy and safety of pamidronate in Modic type 1 changes: study protocol for a prospective randomized controlled clinical trial. Trials 2014; 15: 117.
  • 19.Song H, Luo Y, Wang W, Li S, Yang K, Dai M, et al. Effects of alendronate on lumbar intervertebral disc degeneration with bone loss in ovariectomized rats. Spine J 2017; 17: 995-1003.
APA Canbek U, HAZER D, Rosberg H, Akgun U, DÜBEKTAŞ CANBEK T, Comert A, karalezli n, Aydogan N (2019). The Effect of Bisphosphonates on Lumbar Vertebral Disc Height. , 52 - 56.
Chicago Canbek Umut,HAZER Derya Burcu,Rosberg Hans-Eric,Akgun Ulas,DÜBEKTAŞ CANBEK TUĞBA,Comert Ayhan,karalezli nazim,Aydogan Nevres Hurriyet The Effect of Bisphosphonates on Lumbar Vertebral Disc Height. (2019): 52 - 56.
MLA Canbek Umut,HAZER Derya Burcu,Rosberg Hans-Eric,Akgun Ulas,DÜBEKTAŞ CANBEK TUĞBA,Comert Ayhan,karalezli nazim,Aydogan Nevres Hurriyet The Effect of Bisphosphonates on Lumbar Vertebral Disc Height. , 2019, ss.52 - 56.
AMA Canbek U,HAZER D,Rosberg H,Akgun U,DÜBEKTAŞ CANBEK T,Comert A,karalezli n,Aydogan N The Effect of Bisphosphonates on Lumbar Vertebral Disc Height. . 2019; 52 - 56.
Vancouver Canbek U,HAZER D,Rosberg H,Akgun U,DÜBEKTAŞ CANBEK T,Comert A,karalezli n,Aydogan N The Effect of Bisphosphonates on Lumbar Vertebral Disc Height. . 2019; 52 - 56.
IEEE Canbek U,HAZER D,Rosberg H,Akgun U,DÜBEKTAŞ CANBEK T,Comert A,karalezli n,Aydogan N "The Effect of Bisphosphonates on Lumbar Vertebral Disc Height." , ss.52 - 56, 2019.
ISNAD Canbek, Umut vd. "The Effect of Bisphosphonates on Lumbar Vertebral Disc Height". (2019), 52-56.
APA Canbek U, HAZER D, Rosberg H, Akgun U, DÜBEKTAŞ CANBEK T, Comert A, karalezli n, Aydogan N (2019). The Effect of Bisphosphonates on Lumbar Vertebral Disc Height. Ege Klinikleri Tıp Dergisi, 57(1), 52 - 56.
Chicago Canbek Umut,HAZER Derya Burcu,Rosberg Hans-Eric,Akgun Ulas,DÜBEKTAŞ CANBEK TUĞBA,Comert Ayhan,karalezli nazim,Aydogan Nevres Hurriyet The Effect of Bisphosphonates on Lumbar Vertebral Disc Height. Ege Klinikleri Tıp Dergisi 57, no.1 (2019): 52 - 56.
MLA Canbek Umut,HAZER Derya Burcu,Rosberg Hans-Eric,Akgun Ulas,DÜBEKTAŞ CANBEK TUĞBA,Comert Ayhan,karalezli nazim,Aydogan Nevres Hurriyet The Effect of Bisphosphonates on Lumbar Vertebral Disc Height. Ege Klinikleri Tıp Dergisi, vol.57, no.1, 2019, ss.52 - 56.
AMA Canbek U,HAZER D,Rosberg H,Akgun U,DÜBEKTAŞ CANBEK T,Comert A,karalezli n,Aydogan N The Effect of Bisphosphonates on Lumbar Vertebral Disc Height. Ege Klinikleri Tıp Dergisi. 2019; 57(1): 52 - 56.
Vancouver Canbek U,HAZER D,Rosberg H,Akgun U,DÜBEKTAŞ CANBEK T,Comert A,karalezli n,Aydogan N The Effect of Bisphosphonates on Lumbar Vertebral Disc Height. Ege Klinikleri Tıp Dergisi. 2019; 57(1): 52 - 56.
IEEE Canbek U,HAZER D,Rosberg H,Akgun U,DÜBEKTAŞ CANBEK T,Comert A,karalezli n,Aydogan N "The Effect of Bisphosphonates on Lumbar Vertebral Disc Height." Ege Klinikleri Tıp Dergisi, 57, ss.52 - 56, 2019.
ISNAD Canbek, Umut vd. "The Effect of Bisphosphonates on Lumbar Vertebral Disc Height". Ege Klinikleri Tıp Dergisi 57/1 (2019), 52-56.